✦ LIBER ✦

Tu1244 Are Accelerated Infliximab Infusions Safe to Administer in Patients With Inflammatory Bowel Disease?

✍ Scribed by Parvulescu-Codrea, Simona; Behm, Brian W.; Finke, Karen; Snyder, Kathryn; Hill, Beth; Tuskey, Anne G.; McConnell, John; Dunkle, Elizabeth; Cox, Debbie; Woodward, Beth; Eichner, Tammy

Book ID: 122310295
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 66 KB
Volume: 142
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(12)63038-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Are accelerated infliximab infusions saf

Are accelerated infliximab infusions safe in patients with inflammatory bowel disease?

✍ Shivaram Bhat; Divyesh Sharma; Pauline Doherty; Tony C.K. Tham; Grant R. Caddy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Background: Infliximab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD). The manufacturerrecommended administration is over 2 hours followed by 2 hours of patient observation. The data relating to adverse outcomes in patients receiving accelerated infusions for IBD

Tolerability of one hour 10mg/kg inflixi

Tolerability of one hour 10mg/kg infliximab infusions in patients with inflammatory bowel disease

✍ Babouri, Abdenour; Buisson, Anthony; Bigard, Marc-André; Peyrin-Biroulet, Lauren 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 238 KB

Severe infusion reactions to infliximab:

Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease

✍ C. Steenholdt; M. Svenson; K. Bendtzen; O. Ø. Thomsen; J. Brynskov; M. A. Ainswo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB

Su1393 Primary Non Response to Inflixima

Su1393 Primary Non Response to Infliximab in Patients With Inflammatory Bowel Disease

✍ Papamichael, Konstantinos; Gazouli, Maria; Tsirogianni, Alexandra; Archavlis, Em 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

W1201 Out-Patient Administration of One-

W1201 Out-Patient Administration of One-Hour Infliximab Infusions in Pediatric Inflammatory Bowel Disease Patients with Minimal Premedication

✍ Gobin, Tamara S.; Cohen, Stanley A.; Saripkin, Cathy J.; Stallworth, Angela N.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Tu1173 Infliximab Trough Levels (IFX-Tl)

Tu1173 Infliximab Trough Levels (IFX-Tl) Are Higher in Patients With Inflammatory Bowel Disease (IBD)Treated With Immunosuppressives: Clinical Correlations of IFX-LT and Antibodies to Infliximab (ATI) in IBD

✍ Daperno, Marco; Lavagna, Alessandro; Fracchia, Mario; Guiotto, Cristina; Germano 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB